Invivyd, INC Form 4 insider transactions

Invivyd, Inc. reports that Director Ajay Royan acquired 50,000 stock options with an exercise price of $1.04.

Invivyd, Inc. director Kevin F. McLaughlin acquired 50,000 stock options with an exercise price of $1.04, vesting in full by May 19, 2027.

Invivyd, Inc. reports that Director Terrance McGuire was granted 50,000 stock options with an exercise price of $1.04.

Invivyd, Inc. reports the grant of 50,000 stock options to Marc Elia, a director and other significant stakeholder, with a potential vesting date in May 2027.

Invivyd, Inc. reports that Director Paul Bolno acquired stock options, indicating a potential long-term commitment to the company.

Invivyd, Inc. director Tamsin Berry has acquired 50,000 stock options with an exercise price of $1.04, vesting in full by May 2027.

Invivyd's Chief Scientific Officer, Robert D. Allen III, sold a portion of his common stock to cover tax liabilities following the vesting of restricted stock units.

Invivyd's Chief Human Resources Officer, Julie Green, reported the vesting of 99,000 restricted stock units and subsequent sales of 40,627 shares to cover tax obligations.

Invivyd's Chief Financial Officer, William E. Duke, sold shares to cover tax obligations following the vesting of restricted stock units.

Invivyd's Chief Commercial Officer, Timothy Edward Lee, reported the sale of common stock to cover tax withholding obligations following the vesting of restricted stock units.

Invivyd's Chief Legal Officer, Jill Andersen, reported the sale of common stock to cover tax obligations following the vesting of restricted stock units.

Invivyd, Inc.'s Chief Financial Officer, William E. Duke, was granted 625,000 stock options with an exercise price of $1.85, vesting over three years.

Invivyd, Inc.'s Chief Human Resources Officer, Julie Green, was granted 675,000 stock options with an exercise price of $1.85, vesting over three years.

Invivyd's Chief Commercial Officer, Timothy Edward Lee, was granted 675,000 stock options with an exercise price of $1.85, vesting over three years.

Invivyd, Inc.'s Chief Legal Officer, Jill Andersen, was granted 820,000 stock options with an exercise price of $1.85, vesting over three years.

Invivyd's Chief Scientific Officer, Robert D. Allen III, was granted 625,000 stock options with an exercise price of $1.85, vesting over three years.

Invivyd Inc. Director Kevin F. McLaughlin purchased 50,000 shares of common stock at $2.50 each through an underwritten public offering.

Invivyd, Inc. Director Paul Bolno was granted 100,000 stock options with an exercise price of $1.22, vesting over a three-year period.

Invivyd's Chief Commercial Officer, Timothy Edward Lee, sold shares to cover tax obligations following the vesting of restricted stock units, as part of a pre-arranged 10b5-1 plan.

Invivyd's Chief Financial Officer, William E. Duke, sold 49,656 shares of common stock to cover tax obligations following the vesting of 99,000 restricted stock units.

Invivyd's Chief Human Resources Officer, Julie Green, sold shares to cover tax obligations following the vesting of Restricted Stock Units.

Invivyd's Chief Legal Officer, Jill Andersen, sold shares to cover tax obligations following the vesting of restricted stock units.

Invivyd's Chief Scientific Officer, Robert D. Allen III, sold shares to cover tax obligations following the vesting of restricted stock units.

Terrance McGuire, a director of Invivyd, Inc., was granted stock options to purchase 50,000 shares of common stock.

Director Tamsin Berry acquired 50,000 stock options in Invivyd, Inc. on May 20, 2025, according to a Form 4 filing.

Director Kevin F. McLaughlin reports the acquisition of stock options in Invivyd, Inc.

Marc Elia, a director of Invivyd, Inc., was granted a stock option for 50,000 shares on May 20, 2025, as reported in a Form 4 filing.

Christine Lindenboom, a director of Invivyd, Inc., was granted stock options to purchase 50,000 shares of common stock.

Director Ajay Royan acquired stock options in Invivyd, Inc. on May 20, 2025.

Director Ajay Royan acquired stock options for 100,000 shares of Invivyd, Inc. at an exercise price of $0.724 on March 24, 2025.